-
1by Omid Safa, Mehdi Hassaniazad, Mehdi Farashahinejad, Parivash Davoodian, Habib Dadvand, Soheil Hassanipour, Mohammad Fathalipour“... ill. Trial design This is a single center, randomized, double-blind, placebo-controlled clinical trial...”
Published 2020-10-01
Get full text
Article -
2by Fatemeh Sadat Hosseini, Alireza Malektojari, Sara Ghazizadeh, Mehdi Hassaniazad, Parivash Davoodian, Habib Dadvand, Amin Reza Nikpoor, Sara Nikoofal-Sahlabadi, Sara Kahoori, Mojtaba Sepandi, Soheil Hassanipour, Mohammad Fathalipour“... and moderately severe COVID-19. Trial design This is a phase 3, single-center, randomized, open-label, controlled...”
Published 2021-01-01
Get full text
Article -
3by Ali Ameri, Masoomeh Frouz Asadi, Manoochehr Kamali, Majid Vatankhah, Ava Ziaei, Omid Safa, Masoomeh Mahmudi, Mohammad Fathalipour“... are admitted to the Intensive Care Unit (ICU). Trial design This is a single-center, open-label, randomized...”
Published 2021-03-01
Get full text
Article -
4by Omid Safa, Mehdi Hassani-Azad, Mehdi Farashahinejad, Parivash Davoodian, Habib Dadvand, Soheil Hassanipour, Mohammad Fathalipour“... and laboratory signs in patients with confirmed COVID-19 that are moderately ill. Trial design This is a single...”
Published 2020-09-01
Get full text
Article -
5“... are moderately ill. Trial design This is a phase 3, single-center, randomized, open-label, controlled trial...”
Get full text
Article -
6by Mehdi Hassaniazad, Behnaz Rahnama Inchehsablagh, Hossein Kamali, Abdolali Tousi, Ebrahim Eftekhar, Mahmoud Reza Jaafari, Mohammad Fathalipour, Sara Nikoofal-Sahlabadi, Hamed Gouklani, Hesam Alizade, Amin Reza Nikpoor“... changes following treatment. Trial design This study is conducted as a prospective, placebo-controlled...”
Published 2020-10-01
Get full text
Article